NIH Guide: Weekly Index | grants.nih.gov

Weekly NIH Funding Opportunities and Notices

April 14, 2023

General Notices

Request for Information (RFI): Understanding the Creation, Continuation, and Consequences of Illicit Drug Markets
(NOT-DA-23-023)

National Institute on Drug Abuse
Request for Information (RFI): Food is Medicine Research Opportunities
(NOT-OD-23-107)

Office of Nutrition Research

Agency for Healthcare Research and Quality

National Institute on Aging

National Cancer Institute

National Institute of Dental and Craniofacial Research

National Institute of Diabetes and Digestive and Kidney Diseases

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Heart, Lung, and Blood Institute

National Institute of Mental Health

Office of the Director, NIH

National Center for Complementary and Integrative Health

Office of Research on Women's Health

Office of Dietary Supplements

Office of AIDS Research

Food and Drug Administration

Office of Disease Prevention

National Institute on Minority Health and Health Disparities

Notice of Changes to Funding Opportunities

Notice of Early Expiration of PAR-21-112, "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)"
(NOT-AG-23-019)

National Institute on Aging
Notice of Change in Funding Opportunity Purpose of NIDCR Small Research Grants for Analyses of Existing Genomics Data (PAR-23-132)
(NOT-DE-23-009)

National Institute of Dental and Craniofacial Research
Notice to update Section IV. Application and Submission Information - Specific Aims and Research Strategy: for PAR-21-178 - Drug Development Tools Research Grants (U01) Clinical Trial Optional
(NOT-FD-23-009)

Food and Drug Administration
Notice to Extend the Application Due Date for RFA-FD-23-019 - Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
(NOT-FD-23-010)

Food and Drug Administration
Notice to Extend the Application Due Date for RFA-FD-23-027- Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed
(NOT-FD-23-011)

Food and Drug Administration
Notice of Change of the Locus of Review, Application Types Allowed and Expiration date for PAR-23-097, "Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)"
(NOT-MH-23-205)

National Institute of Mental Health
Notice of Change of the Locus of Review for PAR-23-102, "Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)"
(NOT-MH-23-206)

National Institute of Mental Health
Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
(NOT-TR-23-008)

National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences
Notice of Termination of PAR-22-101 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
(NOT-TR-23-009)

National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences

Notices of Intent to Publish

Notice of Intent to Publish a Notice of Funding Opportunity for the PATCH-IN Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
(NOT-HD-23-009)

Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
(NOT-HG-23-034)

National Human Genome Research Institute
Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
(NOT-HG-23-035)

National Human Genome Research Institute

Notices of Special Interest

Notice of Special Interest (NOSI): Assembling the Addiction Organelle Interactome
(NOT-DA-24-007)

National Institute on Drug Abuse
Notice of Special Interest (NOSI): NIDCD National Research Service Award (NRSA) T32 and T35 Diversity Administrative Supplement
(NOT-DC-23-010)

National Institute on Deafness and Other Communication Disorders
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications.
(NOT-EB-23-002)

National Institute of Biomedical Imaging and Bioengineering

National Institute on Aging

National Institute of Allergy and Infectious Diseases

National Institute of General Medical Sciences

National Cancer Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Heart, Lung, and Blood Institute

National Center for Complementary and Integrative Health
Notice of Special Interest (NOSI): EXposome in Autoimmune Disease Collaborating Teams PLANning Awards (EXACT-PLAN) (Clinical Trials Not Allowed)
(NOT-OD-23-112)

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute on Aging

National Institute of Dental and Craniofacial Research

National Institute of Environmental Health Sciences

National Eye Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Center for Complementary and Integrative Health

Office of Research on Women's Health

Funding Opportunities

Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
(PAR-23-098)

National Human Genome Research Institute

National Institute of Mental Health

Application Receipt Date(s): June 22, 2025
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
(PAR-23-119)

National Institute of Diabetes and Digestive and Kidney Diseases

Application Receipt Date(s): January 7, 2025
Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
(PAR-23-154)

National Institute of Neurological Disorders and Stroke

National Institute on Aging

Application Receipt Date(s): October 20, 2023
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
(PAR-23-155)

National Cancer Institute

Application Receipt Date(s): August 9, 2023
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
(PAR-23-157)

National Institute on Drug Abuse

Application Receipt Date(s): Multiple dates, see announcement.
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
(PAR-23-158)

National Institute on Drug Abuse

Application Receipt Date(s): Multiple dates, see announcement.
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
(PAR-23-159)

National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Application Receipt Date(s): October 17, 2024
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
(PAR-23-160)

National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Application Receipt Date(s): October 17, 2024
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
(PAR-23-163)

National Institute on Aging

Application Receipt Date(s): September 25, 2023
Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
(PAR-23-171)

National Institute of Neurological Disorders and Stroke

National Institute of Allergy and Infectious Diseases

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Dental and Craniofacial Research

National Institute of Environmental Health Sciences

National Eye Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Human Genome Research Institute

National Heart, Lung, and Blood Institute

National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences

Application Receipt Date(s): May 15, 2025
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
(RFA-AI-23-023)

National Institute of Allergy and Infectious Diseases

Application Receipt Date(s): Multiple dates, see announcement.
Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed
(RFA-FD-23-022)

Food and Drug Administration

Application Receipt Date(s): June 20, 2023
Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)
(RFA-MH-23-105)

National Institute of Mental Health

Application Receipt Date(s): June 14, 2023
Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-MH-23-106)

National Institute of Mental Health

Application Receipt Date(s): June 14, 2023
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
(RFA-MH-23-270)

National Institute of Mental Health

National Institute on Alcohol Abuse and Alcoholism

National Institute on Aging

National Institute on Drug Abuse

National Institute on Deafness and Other Communication Disorders

National Eye Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Neurological Disorders and Stroke

National Center for Complementary and Integrative Health

National Institute of Biomedical Imaging and Bioengineering

Application Receipt Date(s): June 7, 2024
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
(RFA-MH-23-330)

National Institute of Mental Health

National Institute on Alcohol Abuse and Alcoholism

National Institute on Aging

National Institute on Drug Abuse

National Institute on Deafness and Other Communication Disorders

National Eye Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Neurological Disorders and Stroke

National Center for Complementary and Integrative Health

National Institute of Biomedical Imaging and Bioengineering

Application Receipt Date(s): Multiple dates, see announcement.
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
(RFA-MH-23-331)

National Institute of Mental Health

National Institute on Alcohol Abuse and Alcoholism

National Institute on Aging

National Institute on Drug Abuse

National Institute on Deafness and Other Communication Disorders

National Eye Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Neurological Disorders and Stroke

National Center for Complementary and Integrative Health

National Institute of Biomedical Imaging and Bioengineering

Application Receipt Date(s): Multiple dates, see announcement.
Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
(RFA-TR-23-010)

National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences

National Institute on Alcohol Abuse and Alcoholism

National Institute on Aging

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute on Drug Abuse

National Institute of Dental and Craniofacial Research

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Neurological Disorders and Stroke

National Center for Complementary and Integrative Health

Application Receipt Date(s): May 22, 2023

Technical Issues: E-mail OER Webmaster